Raising liquidity against a shareholding is straightforward enough for an ordinary investor. For a director or senior executive of the company whose shares are being pledged, there is a governance layer sitting above the transaction that has to be handled properly.
None of it usually prevents the loan. But getting the sequence wrong can turn a routine financing into a market disclosure problem, and occasionally into something worse.
Why Regulators Care About Pledged Director Shares
The concern is straightforward. If a director has pledged a substantial part of their holding as collateral, and the share price falls far enough for the lender to sell, a large block can hit the market suddenly and without warning. Other shareholders arguably ought to know that risk exists.
There is also a signalling dimension. A director borrowing heavily against their own company’s stock may be read by the market as a statement about their confidence or their personal finances, whether or not that reading is fair.
That is the logic behind the disclosure regimes. The specific requirements vary by jurisdiction and by the market the company is listed on, which is precisely why this needs establishing case by case rather than assumed.
The Four Things to Establish First
1. What the company’s own share dealing code says. Most listed companies have an internal code governing transactions by directors and persons discharging managerial responsibilities. Many treat pledging as a dealing requiring prior clearance, typically from the chairman or company secretary. Read the actual code rather than relying on what a colleague did last year.
2. Whether you are in a closed period. Companies operate closed periods ahead of results announcements during which directors generally cannot deal. Whether a pledge counts as dealing depends on the regime and the company’s code, but the safe assumption is that it might.
3. Whether the transaction is notifiable. Depending on the market, a pledge of shares by a director may need to be notified to the company and announced to the market within a short deadline. These deadlines are short and missing them is a compliance failure in its own right, separate from the loan.
4. Whether the articles or a shareholders’ agreement restrict it. Private companies frequently have transfer restrictions, pre-emption rights or outright prohibitions on charging shares. These bite regardless of listing status and are often forgotten until a lender’s solicitor raises them.
Your company secretary and your own legal adviser should confirm all four. A broker can tell you what lenders will want; they cannot tell you what your specific obligations are.
How This Affects the Loan Itself
The governance position shapes the structure more than people expect.
Size relative to your holding. Pledging a modest proportion of your stake is a very different signal, and a very different risk, from pledging most of it. Boards are markedly more comfortable with the former.
Margin call exposure. A facility that could force a sale of director shares in a falling market is the scenario everyone is trying to avoid. This is one reason directors often prefer structures where liability is limited to the pledged shares, or where margin call provisions are constrained — the trade-offs are set out on our recourse and non-recourse page.
Voting rights. Under most structures you retain beneficial ownership and voting rights, with the shares held by a regulated custodian for the term. For a director this matters more than for an ordinary investor, and it is worth confirming explicitly in the documentation. Our share custodian process page explains how custody works.
Confidentiality. The loan terms themselves are private between you and the lender. What may need disclosing is the fact of the pledge, not its commercial terms.
Sequencing It Properly
The order matters, and it is not the order people instinctively follow.
Establish the disclosure and approval position before agreeing terms, not after. Obtain any internal clearance required. Agree the facility and its documentation. Complete, and then make any required notification within the deadline.
The failure mode is agreeing a facility, discovering at legal diligence that board consent is needed, and then having to raise it with a board that would have preferred to hear about it earlier. That conversation goes considerably better when it happens first.
Restricted and Legended Stock
Where the shares carry US resale restrictions, an additional layer applies. Volume limits, holding periods and filing requirements affect both what a lender can do with the collateral and what you can do to repay. Our Rule 144 restricted stock loans page covers financing against that stock.
Similar considerations arise with shares subject to post-flotation lock-ups or to contractual orderly-market arrangements.
Frequently Asked Questions
Does pledging shares always have to be announced publicly?
Not always — it depends on the market, the company’s own code and the size of the pledge. Some regimes require notification of pledges by directors; others do not. Establish your specific position rather than assuming either way.
Can I pledge shares during a closed period?
Often not, and the safe planning assumption is that you cannot. Facilities are usually timed around results announcements for exactly this reason, which is worth building into your schedule if you have a deadline.
Will the lender contact my company?
Where consent or acknowledgement is required under the articles, or where the company must be notified, yes. This is normal and handled through solicitors, but it is another reason to have raised it internally first.
Does the board have to approve it?
Under many internal dealing codes, clearance is required rather than full board approval — typically from the chairman or company secretary. Private company articles may impose stricter requirements.
Note that disclosure obligations vary by jurisdiction, listing venue and the company’s own rules, and they change. Your company secretary and legal adviser should confirm your specific position; we arrange the lending once that is clear.
You can see the full range of securities-backed facilities we arrange on our homepage, read more on our stock loans and securities-backed lending pages, or contact our team for a confidential discussion.